Re: Update from IR -- Eversana paused?
in response to
by
posted on
Dec 17, 2022 08:21AM
Tex,
Chris replied with "financing". How does a company raise additional capital with a share price of 12 cents. Financing implies continue operations. Really not a good sign when when item 2 states. "2. Clinical development of apabetalone". That is all we have heard since BoM bombed. Need a little help, why would a pharma include unknown issues, i.e. stroke, in a P3 test. Seems if they just stayed with P2b, the increase of HDL and reducing Type 2, RVX would be in the money. sidebar